StockData
DataMeds AI, Inc. logo

DataMeds AI, Inc. (MEDS) stock

MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.74+0.10 (+15.41%)

Close on Nov 18, 2026Market cap $2.26MP/E –Yield –

DataMeds AI revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

DataMeds AI's revenue for the twelve months ending Sep 30, 2026 was $7.68M, down 77.5% year over year. For fiscal 2025 it was $23.34M, up 28.7% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$23.34M+28.7%
FY2024Dec 31, 2024$18.13M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.67M-11.4%
Q2 FY2026Jun 30, 2026$1.78M-77.2%
Q1 FY2026Mar 31, 2026$1.56M-85.6%
Q4 FY2025Dec 31, 2025$1.67M-86.5%
Q3 FY2025Sep 30, 2025$3.01M-46.9%
Q2 FY2025Jun 30, 2025$7.79M+17391.8%
Q1 FY2025Mar 31, 2025$10.86M–
Q4 FY2024Dec 31, 2024$12.41M–
Q3 FY2024Sep 30, 2024$5.67M–
Q2 FY2024Jun 30, 2024$44.54K–

More DataMeds AI figures

See a number that looks wrong?